Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics granted inducement stock options to eight new employees on July 1, covering an aggregate of 238,700 shares of common stock. The options have an exercise price of $10.18, matching the closing price on the grant date, and vest over four years with full vesting expected by July 1, 2030.
Key figures
- New employees
- 8
- Exercise price
- 10.18
- Options granted
- 238700
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.